Європейський Союз - грецька - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Εμβόλια - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.

Кіпр - грецька - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

laboratorios rubio, s.a. (0000010596) industria, 29 - pol. ind. comte de sert, castellbisbal, barcelona, 08755 - sodium polystyrene sulfonate - powder for oral suspension - 99.75g/100g - sodium polystyrene sulfonate (0009003592) 99,75g

Греція - грецька - Εθνικός Οργανισμός Φαρμάκων

mylan pharmaceuticals limited, ireland damastown industrial park, - dublin - bosentan monohydrate - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 62.5mg/tab - bosentan monohydrate 64,541mg - bosentan

Греція - грецька - Εθνικός Οργανισμός Φαρμάκων

mylan pharmaceuticals limited, ireland damastown industrial park, - dublin - bosentan monohydrate - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 125mg/tab - bosentan monohydrate 129,082mg - bosentan

Греція - грецька - Εθνικός Οργανισμός Φαρμάκων

mylan s.a.s., saint priest, france - ΥΔΡΟΒΡΩΜΙΚΉ ΓΚΑΛΑΝΤΑΜΊΝΗ - ΚΑΨΑΚΙΟ ΠΑΡΑΤΕΤΑΜΕΝΗΣ ΑΠΟΔΕΣΜΕΥΣΗΣ, ΣΚΛΗΡΟ - 24mg/cap - 0001953044 - galantamine hydrobromide - 30.768000 mg - galantamine

Греція - грецька - Εθνικός Οργανισμός Φαρμάκων

mylan s.a.s., saint priest, france - ΥΔΡΟΒΡΩΜΙΚΉ ΓΚΑΛΑΝΤΑΜΊΝΗ - ΚΑΨΑΚΙΟ ΠΑΡΑΤΕΤΑΜΕΝΗΣ ΑΠΟΔΕΣΜΕΥΣΗΣ, ΣΚΛΗΡΟ - 8mg/cap - 0001953044 - galantamine hydrobromide - 10.256000 mg - galantamine

Греція - грецька - Εθνικός Οργανισμός Φαρμάκων

elpen ae ΦΑΡΜΑΚΕΥΤΙΚΗ ΒΙΟΜΗΧΑΝΙΑ Λεωφ. Μαραθώνος 95,, 190 09 190 09, Πικέρμι 6039326 - bosentan monohydrate - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 125mg/tab - bosentan monohydrate 129,08mg - bosentan

Греція - грецька - Εθνικός Οργανισμός Φαρμάκων

elpen ae ΦΑΡΜΑΚΕΥΤΙΚΗ ΒΙΟΜΗΧΑΝΙΑ Λεωφ. Μαραθώνος 95,, 190 09 190 09, Πικέρμι 6039326 - bosentan monohydrate - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 62.5mg/tab - bosentan monohydrate 64,54mg - bosentan

Греція - грецька - Εθνικός Οργανισμός Φαρμάκων

bausch health ireland limited, ireland 3013 lake drive, d24ppt3 dublin 24 - bosentan monohydrate - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 125mg/tab - bosentan monohydrate 129,08mg - bosentan

Греція - грецька - Εθνικός Οργανισμός Φαρμάκων

bausch health ireland limited, ireland 3013 lake drive, d24ppt3 dublin 24 - bosentan monohydrate - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 62.5mg/tab - bosentan monohydrate 64,54mg - bosentan